Dow Up 1.31% Nasdaq Up 2.40%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
5.56 0.22(4.12%) Oct 21, 4:00PM EDT
Prev Close:5.34
Open:5.38
Bid:5.26 x 900
Ask:8.88 x 1300
1y Target Est:8.33
Beta:1.18
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:5.30 - 5.59
52wk Range:4.09 - 8.25
Volume:89,535
Avg Vol (3m):82,519
Market Cap:240.94M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIUp 4.12%240.94M
ABT63.74B
AMGN109.45B
AZN87.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):102.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.14
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback